The selection of the <i>UBC9</i> gene and its c.73G>A polymorphism (rs11553473) in breast cancer studies is justified by the gene's critical role in sumoylation, its impact on DNA repair, and its association with aggressive tumor characteristics. This evidence concerns the gene UBE2I and breast cancer.